Cardiff Oncology (CRDF) EBT Margin (2016 - 2025)
Historic EBT Margin for Cardiff Oncology (CRDF) over the last 15 years, with Q3 2025 value amounting to 9381.67%.
- Cardiff Oncology's EBT Margin fell 21937900.0% to 9381.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 10065.07%, marking a year-over-year decrease of 38341600.0%. This contributed to the annual value of 6645.97% for FY2024, which is 18259500.0% up from last year.
- According to the latest figures from Q3 2025, Cardiff Oncology's EBT Margin is 9381.67%, which was down 21937900.0% from 11522.31% recorded in Q2 2025.
- Cardiff Oncology's 5-year EBT Margin high stood at 4881.46% for Q1 2024, and its period low was 14964.86% during Q1 2022.
- In the last 5 years, Cardiff Oncology's EBT Margin had a median value of 8137.21% in 2021 and averaged 9183.73%.
- As far as peak fluctuations go, Cardiff Oncology's EBT Margin skyrocketed by 96390200bps in 2024, and later plummeted by -74497300bps in 2025.
- Cardiff Oncology's EBT Margin (Quarter) stood at 7162.41% in 2021, then fell by -2bps to 7337.5% in 2022, then increased by 19bps to 5976.92% in 2023, then crashed by -31bps to 7804.64% in 2024, then decreased by -20bps to 9381.67% in 2025.
- Its last three reported values are 9381.67% in Q3 2025, 11522.31% for Q2 2025, and 12331.19% during Q1 2025.